CVS Health Corporation
CVS Health Reports Lower Q4 and Full-Year 2024 Earnings Due to Health Care Benefits Segment Performance
Summary
CVS Health Corporation reported a decline in Q4 and full-year 2024 earnings, driven by decreased operating income in the Health Care Benefits segment, primarily due to utilization pressure and the impact of Medicare Advantage star ratings. The company's total revenues increased by 4.2% for both periods, and it provided full-year 2025 guidance. The earnings report was furnished as Exhibit 99.1.
Profitelligence Alerts
Get alerts for CVS
Be first to know when CVS Health Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About CVS Health Corporation
CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
Official SEC Documents
Advertisement